Victrex plc (LON:VCT) insider Timothy (Tim) J. Cooper bought 5 shares of Victrex stock in a transaction dated Thursday, January 17th. The shares were bought at an average cost of GBX 2,350 ($30.71) per share, with a total value of £117.50 ($153.53).
Shares of Victrex stock opened at GBX 2,430 ($31.75) on Friday. Victrex plc has a 1 year low of GBX 1,826 ($23.86) and a 1 year high of GBX 2,772 ($36.22).
The firm also recently disclosed a dividend, which will be paid on Friday, February 22nd. Investors of record on Thursday, January 31st will be paid a GBX 128.82 ($1.68) dividend. This is an increase from Victrex’s previous dividend of $13.42. This represents a yield of 5.46%. The ex-dividend date is Thursday, January 31st.
VCT has been the subject of several analyst reports. UBS Group reaffirmed a “buy” rating and set a GBX 3,600 ($47.04) target price (up from GBX 3,300 ($43.12)) on shares of Victrex in a report on Thursday, October 4th. Morgan Stanley downgraded Victrex to an “underweight” rating and reduced their price objective for the stock from GBX 2,500 ($32.67) to GBX 2,300 ($30.05) in a research note on Friday, October 12th. Liberum Capital reissued a “buy” rating on shares of Victrex in a research note on Tuesday, October 16th. Peel Hunt reissued an “add” rating on shares of Victrex in a research note on Tuesday, December 4th. Finally, Barclays reissued an “underweight” rating and issued a GBX 2,420 ($31.62) price objective on shares of Victrex in a research note on Wednesday, December 5th. Three analysts have rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of GBX 2,665.56 ($34.83).
Victrex Company Profile
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. It operates through two segments, Victrex Polymer Solutions and Invibio Biomaterial Solutions. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, dental, trauma, knee, cardiovascular, and orthopedic applications.
Recommended Story: What is a blue-chip stock?
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.